These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20848091)

  • 1. Influence of gestational diabetes mellitus on the stereoselective kinetic disposition and metabolism of labetalol in hypertensive patients.
    Carvalho TM; Cavalli Rde C; Cunha SP; de Baraldi CO; Marques MP; Antunes NJ; Godoy AL; Lanchote VL
    Eur J Clin Pharmacol; 2011 Jan; 67(1):55-61. PubMed ID: 20848091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
    Riva E; Mennini T; Latini R
    Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol pharmacokinetics and pharmacodynamics: evidence of stereoselective disposition.
    Lalonde RL; O'Rear TL; Wainer IW; Drda KD; Herring VL; Bottorff MB
    Clin Pharmacol Ther; 1990 Nov; 48(5):509-19. PubMed ID: 2225711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial.
    Shekhar S; Sharma C; Thakur S; Verma S
    Obstet Gynecol; 2013 Nov; 122(5):1057-1063. PubMed ID: 24104790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects.
    Chan SW; Hu M; Ko SS; Tam CW; Fok BS; Yin OQ; Chow MS; Tomlinson B
    Eur J Clin Pharmacol; 2013 Apr; 69(4):799-806. PubMed ID: 23090703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labetalol disposition and concentration-effect relationships during pregnancy.
    Rubin PC; Butters L; Kelman AW; Fitzsimons C; Reid JL
    Br J Clin Pharmacol; 1983 Apr; 15(4):465-70. PubMed ID: 6849783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective analysis of labetalol in human plasma by LC-MS/MS: application to pharmacokinetics.
    Carvalho TM; Cavalli Rde C; Marques MP; Da Cunha SP; Baraldi Cde O; Lanchote VL
    Chirality; 2009 Aug; 21(8):738-44. PubMed ID: 19006203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
    Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.
    Raheem IA; Saaid R; Omar SZ; Tan PC
    BJOG; 2012 Jan; 119(1):78-85. PubMed ID: 21985500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs.
    Horikiri Y; Suzuki T; Mizobe M
    J Pharm Sci; 1997 May; 86(5):560-4. PubMed ID: 9145379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy.
    Clark SM; Dunn HE; Hankins GD
    Semin Perinatol; 2015 Nov; 39(7):548-55. PubMed ID: 26344738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between plasma concentrations and pharmacological effects of labetalol.
    Richards DA; Maconochie JG; Bland RE; Hopkins R; Woodings EP; Martin LE
    Eur J Clin Pharmacol; 1977 Jan; 11(2):85-90. PubMed ID: 14010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of gestational diabetes on the stereoselective pharmacokinetics and placental distribution of metoprolol and its metabolites in parturients.
    Antunes Nde J; Cavalli RC; Marques MP; Moisés EC; Lanchote VL
    Br J Clin Pharmacol; 2015 Apr; 79(4):605-16. PubMed ID: 25291152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokinetic-dynamic analysis.
    Saotome T; Minoura S; Terashi K; Sato T; Echizen H; Ishizaki T
    J Clin Pharmacol; 1993 Oct; 33(10):979-88. PubMed ID: 8227470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive chiral high-performance liquid chromatographic assay for labetalol in biological fluids.
    Dakers JM; Boulton DW; Fawcett JP
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):215-20. PubMed ID: 9518153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.
    Daneshmend TK; Roberts CJ
    Br J Clin Pharmacol; 1982 Jul; 14(1):73-8. PubMed ID: 7104169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers.
    Cheymol G; Poirier JM; Carrupt PA; Testa B; Weissenburger J; Levron JC; Snoeck E
    Br J Clin Pharmacol; 1997 Jun; 43(6):563-70. PubMed ID: 9205815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological properties of (+/-)-4-[2-hydroxy-3-(3-(2-methoxyphenoxy)-2-propylamino)propoxy]-1(2H) -isoquinolinone (N-1518), a new combined alpha- and beta-adrenoceptor blocking drug].
    Sugai T
    Nihon Yakurigaku Zasshi; 1990 Sep; 96(3):117-27. PubMed ID: 1980255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To study the changes in maternal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension.
    Thakur M; Gainder S; Saha SC; Prakash M
    Pregnancy Hypertens; 2020 Jul; 21():180-183. PubMed ID: 32570152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.